Today NICE published their Advice on “AMBLor for identifying low-risk non-ulcerated early-stage cutaneous melanomas”. This formal external review and publication is a significant step in getting AMBLor® adopted into clinical care pathways in the UK. It follows on from...
AMLo Biosciences Limited is a company registered in England and Wales. Company # 11004534
Trading address: Office 9, The Biosphere, Drayman's Way, Newcastle Helix, Newcastle upon Tyne, NE4 5BX
Registered address: c/o RMT Accountants & Business Advisors Ltd, Gosforth Park Avenue, Newcastle upon Tyne, NE12 8EG, United Kingdom
VAT # 285288950
Sign up for our newsletter